Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Organigram Stock a Buy?


Retail cannabis sales in Canada have rebounded from a brief dip in February, but Organigram (NASDAQ: OGI) stock hasn't followed. Shares of the licensed cannabis producer have lost about 30% of their value this year.

The company has pushed back its earnings report for the three months ended May. 31, 2020, by a week to compensate for coronavirus-related difficulties experienced during the hectic period. Now that the company's market value has fallen to a sprightly $299 million, bargain shoppers are wondering if the stock is a buy right now.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
OGI
Share

Comments